<?xml version="1.0" encoding="UTF-8"?>
<p>Currently, nine clinical studies evaluating the role of remdesivir in COVID-19 is underway (
 <xref rid="T3" ref-type="table">Table 3</xref>). Results of these trials will present evidence about the status of this drug, as a treatment option in SARS-CoV-2 infection. In most published studies, remdesivir was found to decrease the duration of recovery time making faster healing in some COVID-19 illness, but the effectiveness and safety of this molecule is yet to be known.
 <sup>
  <xref rid="B16" ref-type="bibr">16</xref>
 </sup> Hopefully, there will be encouraging study results favoring remdesivir, which could be a potential game changer.
</p>
